A systematic framework for predictive biomarkers in immune effector cell-associated neurotoxicity syndrome

Chimeric antigen receptor (CAR)-T cell therapy has revolutionized the management of several life-threatening malignancies, often achieving durable sustained responses. The number of patients treated with this new class of cell-based therapy, along with the number of Food and Drug Association (FDA) a...

Descripción completa

Detalles Bibliográficos
Autores principales: Butt, Omar H., Zhou, Alice Y., Ances, Beau M., DiPersio, John F., Ghobadi, Armin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9969296/
https://www.ncbi.nlm.nih.gov/pubmed/36860569
http://dx.doi.org/10.3389/fneur.2023.1110647

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9969296/
https://www.ncbi.nlm.nih.gov/pubmed/36860569
http://dx.doi.org/10.3389/fneur.2023.1110647

Ejemplares similares